Pre-migration untagged articles
-
The EuroMTN market saw a marked increase in activity this week as investors and issuers returned from their summer breaks ahead of the expected funding flurry at the beginning of September.
-
At the end of last week, a Texas jury ruled against Merck in a case alleging the pharmaceuticals firm's liability concerning the use of the anti-inflammatory drug Vioxx, which was used to treat arthritis. The firm widened 11bp last Friday and another 6bp on Monday to a mid of 40bp.